Artelo Biosciences Stock Forecast

Sell candidate since Jul 20, 2026 Loss -32.57%

The Artelo Biosciences, Inc. stock price gained 4.40% on the last trading day (Thursday, 30th Jul 2026), rising from $0.723 to $0.755. During the last trading day the stock fluctuated 5.08% from a day low at $0.730 to a day high of $0.767. The price has fallen in 7 of the last 10 days and is down by -33.75% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 70 thousand more shares were traded than the day before. In total, 341 thousand shares were bought and sold for approximately $257.67 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.567 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -48.99% during the next 3 months and, with a 90% probability hold a price between $0.289 and $0.88 at the end of this 3-month period.

ARTL Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, July 29, 2026, and so far it has risen 4.40%. Further rise is indicated until a new top pivot has been found. Artelo Biosciences, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Artelo Biosciences, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.93 and $1.12. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Artelo Biosciences, Inc. stock

Artelo Biosciences, Inc. finds support from accumulated volume at $0.723 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0371 between high and low, or 5.08%. For the last week, the stock has had daily average volatility of 11.92%.

Artelo Biosciences, Inc. is oversold on RSI14 (24). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ARTL) For The Upcoming Trading Day Of Friday 31st

For the upcoming trading day on Friday, 31st we expect Artelo Biosciences, Inc. to open at $0.751, and during the day (based on 14 day Average True Range), to move between $0.710 and $0.80, which gives a possible trading interval of +/-$0.0905 (+/-12.74%) up or down from last closing price. If Artelo Biosciences, Inc. takes out the full calculated possible swing range there will be an estimated 12.74% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.723 (4.21%) than the resistance at $0.88 (16.54%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Artelo Biosciences, Inc. stock A Buy?

Artelo Biosciences, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -4.334 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 31, 2026 - $0.751 ( 0.578%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk